Transcend Capital Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-302,773
| Closed | -$209K | – | 434 |
|
|
2020
Q4 | $209K | Sell |
302,773
-85,635
| -22% | -$59.1K | 0.03% | 349 |
|
|
2020
Q3 | $874K | Buy |
388,408
+24,733
| +7% | +$55.7K | 0.16% | 129 |
|
|
2020
Q2 | $1.3M | Sell |
363,675
-117,374
| -24% | -$420K | 0.42% | 69 |
|
|
2020
Q1 | $1.83M | Sell |
481,049
-46
| -0% | -$175 | 0.55% | 54 |
|
|
2019
Q4 | $1.45M | Buy |
+481,095
| New | +$1.45M | 0.39% | 79 |
|